Bu çeviri hazırlanıyor. Bu süre içinde İngilizce orijinal sürümü gösteriyoruz.
İş dünyası · 31.03.19941 dk okuma
Solvay Pharmaceuticals et al.; Withdrawal of Approval of 24 Abbreviated New Drug Applications
Yerel otomatik çeviri · Kaynağın orijinal dili
Özet
The Food and Drug Administration (FDA) is withdrawing approval of 24 abbreviated new drug applications (ANDA's). The holders of the ANDA's notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.
Kaynağın orijinal dili: Federal Register — Health and Human ServicesOrijinal duyuruyu açın →